The Global ENT device (Ear, Nose, and Throat) market is anticipated to at a CAGR of 7.37% between 2019 and 2027 to generate revenue of $29,895 million by 2027. ENT devices are discrete tools used for therapy, diagnosis of any disorders associated with the ear, nose or throat, thereby assisting to define any difficulties related to smell, hearing, speaking or snoring. The ENT device market is primarily driven by the following factors:

• Growth in numbers of geriatric population
• High prevalence state of chronic sinusitis
• Rapid growth in minimally invasive ENT surgeries
• Technological advancement
• Increase in market players in the ENT market
• Increasing customized implants

The important drivers that are increasing the growth of the global ENT device market are high prevalence state of chronic sinusitis and rapid growth in minimally invasive ENT surgeries. Advances in the procedure along with increased preference in the process by both doctors and patients have led to the rise in minimally invasive surgeries. The increasing prevalence of sinusitis is anticipated to create significant opportunities for the manufacturers of ENT devices in the upcoming years.

The products of ENT device market are used extensively for various purposes. Hearing disabilities are generally cured by devices or added supports like hearing tubes, etc., but in some cases, these impairments require surgical procedures. The diagnostic imaging devices market is witnessing significant growth due to the increasing prevalence of chronic diseases and injuries, and the enlarging aging population. Diagnosis of ENT diseases can be carried out through two methods, namely, Screening devices & Endoscopes.

A cochlear implant or hearing implants is an electronic medical device that substitutes the function of the injured inner ear. Image-guided arrangements aim at complementing and augmenting the physician’s capability to comprehend the spatial construction of the anatomy by contributing to imaging systems and other bases of information, such as tracked devices. CO₂ lasers are widely used in the treatment of transoral laryngeal microsurgery, middle ear surgery, oral surgery, nasal, endonasal & endoscopic sinus surgery, tracheobronchial tree, and head & neck surgeries.

High cost of ENT devices and procedures, and high cost of equipment are the major factors hindering the ENT device market. The high cost associated with ENT procedures, due to rising costs of research & development and other fixed and variable costs associated with the medical devices is a major restraining factor. The stigma and high cost of equipment needed to rectify the hearing disorders of the patient who is suffering from the problem of hearing loss can be a big barrier for patients who need help to hear well.

The global ENT device market segments include product Types and End-users.

Product Types are segmented into:

• Surgical devices
  • Radiofrequency (RF) hand pieces
  • Balloon sinus dilation (BSD) devices
  • Powered surgical instruments
  • Ear tubes
  • Voice prosthesis
  • ENT supplies
    • Packaging material
    • Nasal stents & splints
  • Handheld instruments
    • Rhinology instruments
    • Laryngeal instruments
    • Otology instrument
    • Head and neck surgery instruments
    • Other handheld instruments
  • Diagnostic devices
    • Hearing screening device
    • Endoscope
      • Rigid endoscope
        • Sinuscope
        • Otoscopes
      • Flexible endoscopes
        • Laryngoscopes
        • Nasopharyngoscope
        • Rhinoscope
        • Pharyngoscopes
      • Hearing implants
      • Image-guided surgery systems (IGSS)
      • Hearing aids
        • Behind-the-ear
        • In-the-ear
        • Receiver-in-ear
      • CO₂ lasers

End-users are segmented into:

• Hospitals
• ENT clinics
• Home users
• Ambulatory settings

This report covers the present market conditions and the growth prospects of the global ENT devices market for 2019-2027 and considered the revenue generated through the sales of ENT devices for types as well as applications to calculate the market size by considering 2018 as the base year.

Geographically, the global ENT devices market has been segmented on the basis of four major regions, which include:

• North America – The United States & Canada
• Asia-Pacific – China, India, Japan, Australia, South Korea & Rest of APAC
• Europe – The United Kingdom, France, Germany, Spain, Italy & Rest of Europe
• Rest of World- Latin America & Middle East and North Africa

The ENT device market in North America is expected to hold the largest share by 2027 possibilities of the high prevalence rate of the disease and also due to high investment in the healthcare segment. North America holds a market share of approximately 37% in 2018. Rising Pediatric ENT conditions is one of the major issues being faced by the US. According to the National Institute on Deafness and Other Communication Disorders (NIDCD), 2 to 3 of every 1000 children in the US suffer from detectable level hearing loss either in one or both the ears.

On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the ENT device market. Rising population along with the increasing size of the geriatric population is increasing the demand for the devices. Other factors driving the growth of the region are medical tourism, increasing expenditure in the healthcare sector and rising prevalence of the ENT diseases due to a large number of factors such as changing lifestyle, exposure to a high level of noise, environmental issues, etc.

The ENT device market is segmented based on end-user which is sub-divided into Hospitals, ENT clinics, home users & ambulatory settings. Eye Nose Throat devices market based on end-user are mainly driven by hospitals and its surgery rates. These devices are used by different ENT patients. There are many clinics in the world which are specifically doing the surgery for hearing implants and laser treatment. The hearing implants devices and laser devices are mostly used by clinics. Global ENT devices by home user’s applications are majorly driven by hearing aids instruments which are largely prescribed by the doctors or physician. Ambulatory surgery centers (ASCs) settings refer to the healthcare facilities which provides the places where surgeries that do not require hospital admissions.

The major market players in the global ENT device market are:

• Stryker Corporation
• ATOS Medical
• Cochlear Limited
• Karl Storz GmbH & Co. KG
• Olympus Corporation

Company Profiles covers the analysis of important players. Stryker Corporation (Stryker or ‘the company’) is a leading provider of medical devices and instrumentations in the orthopedic and other healthcare specialties market. The company offers products such as grafts used in trauma surgeries and joint auxiliary; surgical navigation systems and surgical equipment; communications systems and endoscopic; emergency medical equipment and patient handling; neurosurgical, spinal devices and neurovascular; as well as other medical device products used in a variety of medical specialties. Olympus is a Japan-based manufacturer of precision machinery and devices for various industries. The medical segment includes three product lines: endoscopes, Endosurgery, and endotherapy.

Key findings of the global ENT device market:

• Increasing prevalence of hearing losses
• Rising popularity of ambulatory care
• Changing demographics have a positive influence due to growing public awareness
• Hearing aids are the majorly used ENT products
• Ambulatory settings are the fastest growing end-user